Myotonic dystrophy type 2 and autoimmune chronic gastritis: an incidental association?-Reference-Cited by-同舟云学术

Myotonic dystrophy type 2 and autoimmune chronic gastritis: an incidental association?

Published:2011-09-24 Issue:6 Volume:32 Page:1249-1250
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Sicurelli Francesco,Mignarri Andrea,Cardani Rosanna,Mondelli Mauro,Carluccio Alessandra,Marino Daniela,Meola Giovanni,Federico Antonio,Dotti Maria Teresa

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-011-0782-2.pdf

Reference4 articles.

1. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664

2. Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatr 80:1293–1295

3. Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A et al (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 10:80–83

4. Tieleman AA, van Vliet J, Jansen JB, van der Kooi AJ, Borm GF, van Engelen BG (2008) Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord 18:646–649

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2;Neurology Genetics;2023-06

2. Adult orbital xanthogranulomatous disease and myotonic dystrophy type 2: coexistence or association?;Canadian Journal of Ophthalmology;2023-06

3. Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2;Frontiers in Neurology;2022-07-18

4. Graves’ disease and celiac disease in a patient with myotonic dystrophy type 2;Neuromuscular Disorders;2018-10